CIK 0001390478 · Non-accelerated filer<br>Smaller reporting company
SELLAS Life Sciences Group, Inc.
Sign in to watch- Ticker
- SLS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 6462005278
- Business address
- 7 TIMES SQUARE, SUITE 2503, NEW YORK, NY, 10036
- Former names
- GALENA BIOPHARMA, INC., Galena Biopharma, Inc., RXI PHARMACEUTICALS CORP
- CORRESP Other Correspondence Between Filers and SEC Staff
- S-3 Offering Registration Statement
- CORRESP Other Correspondence Between Filers and SEC Staff
- S-3/A Offering Registration Statement
- UPLOAD Other SEC-generated Letter
- DEF 14A Proxy Proxy Statement
- UPLOAD Other SEC-generated Letter
- PRER14A Other PRER14A
- CORRESP Other Correspondence Between Filers and SEC Staff
- UPLOAD Other SEC-generated Letter
- PRE 14A Proxy Proxy Statement (Preliminary)
- SC 13G/A Stake Amended Statement of Ownership
- 8-K Event Executive or director change
- S-3 Offering Registration Statement
- 8-K Event Material agreement · New debt or obligation · Shareholder rights changed
- S-8 Other Securities Offered to Employees in Benefit Plans
- 8-K Event Executive or director change
- 8-K Event Delisting notice
- 8-K Event Material agreement
- 10-Q Report Quarterly Report
Page 31 of 64 · 1,276 filings